 |
PDBsum entry 1nmj
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1nmj
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Biol Inorg Chem
9:627-635
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
The solution structure of rat Abeta-(1-28) and its interaction with zinc ion: insights into the scarcity of amyloid deposition in aged rat brain.
|
|
J.Huang,
Y.Yao,
J.Lin,
Y.H.Ye,
W.Y.Sun,
W.X.Tang Dagger.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The amyloid beta-peptide (Abeta) is a major component of insoluble amyloid
deposits in Alzheimer's disease, and the ability of the beta-peptide to exist in
different conformations is dependent on residues 1-28 [beta-(1-28)]. However,
different from humans, no Abeta amyloid deposition has been found in aged rats'
brains. Studying the three-dimensional solution structure of rat Abeta-(1-28)
and the binding circumstance of Zn(2+) is beneficial to a clear understanding of
the potential role of Zn(2+) in Alzheimer-associated neuropathogenesis and to
suggest why there is no amyloid deposition in aged rats' brains. Here we used
nuclear magnetic resonance (NMR) spectroscopy to determine the solution
structure of rat Abeta-(1-28) and the binding constant of Zn(2+) to rat
Abeta-(1-28). Our results suggest that (1) the three-dimensional solution
structure of rat Abeta-(1-28) is more stable than that of human Abeta-(1-28) in
DMSO- d(6) and that a helical region from Glu16 to Val24 exists in the rat
Abeta-(1-28); (2) the affinity of Zn(2+) for rat Abeta-(1-28) is lower than that
for human Abeta-(1-28) and the NMR data suggest that Arg13, His6, and His14
residues provide the primary binding sites for Zn(2+); and (3) the proper
binding of Zn(2+) to rat Abeta-(1-28) can induce the peptide to change to a more
stable conformation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Tong,
Y.Xu,
K.Scearce-Levie,
L.J.Ptácek,
and
Y.H.Fu
(2010).
COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo.
|
| |
Neurogenetics,
11,
41-52.
|
 |
|
|
|
|
 |
V.Tõugu,
A.Karafin,
K.Zovo,
R.S.Chung,
C.Howells,
A.K.West,
and
P.Palumaa
(2009).
Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
|
| |
J Neurochem,
110,
1784-1795.
|
 |
|
|
|
|
 |
X.Dong,
W.Chen,
N.Mousseau,
and
P.Derreumaux
(2008).
Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
|
| |
J Chem Phys,
128,
125108.
|
 |
|
|
|
|
 |
E.Mocchegiani,
C.Bertoni-Freddari,
F.Marcellini,
and
M.Malavolta
(2005).
Brain, aging and neurodegeneration: role of zinc ion availability.
|
| |
Prog Neurobiol,
75,
367-390.
|
 |
|
|
|
|
 |
Y.Mekmouche,
Y.Coppel,
K.Hochgräfe,
L.Guilloreau,
C.Talmard,
H.Mazarguil,
and
P.Faller
(2005).
Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
|
| |
Chembiochem,
6,
1663-1671.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |